新西兰HPV疫苗接种:学校接种项目对青少年疫苗覆盖率的影响
该研究利用新西兰免疫登记数据,重复横断面分析比较学校接种项目(SBVP)与非SBVP地区13岁青少年HPV疫苗接种覆盖率。结果显示2014至2018年女性一剂覆盖率非SBVP地区较低,2013年例外(非SBVP 77.93% vs SBVP 67.13%);2016年混合模式引入后非SBVP地区覆盖率改善,2019至2023年两种模式覆盖率相近;男性2018至2023年SBVP地区较高,2023年分别为79.0%和68.1%;COVID-19期间覆盖率下降,疫情后SBVP地区回升最快。结论为学校接种HPV疫苗在新西兰是成功的。
要点
- 2014至2018年女性一剂HPV疫苗覆盖率非SBVP地区低于SBVP地区,2013年例外为非SBVP 77.93% vs SBVP 67.13%。
- 2016年坎特伯雷引入混合学校与初级保健提供者项目后非SBVP地区覆盖率改善,2019至2023年两种模式覆盖率相近。
- 2023年男性HPV疫苗覆盖率SBVP地区79.0% vs 非SBVP地区68.1%;COVID-19期间覆盖率下降,疫情后SBVP地区回升最快。
核心结论
- 新西兰学校接种HPV疫苗对青少年是成功的,坎特伯雷非SBVP模式下覆盖率较低,但2016年引入混合学校与初级保健提供者项目后覆盖率似乎有所改善。
研究设计与样本
- 重复横断面分析,使用新西兰免疫登记(Aotearoa Immunization Register)的HPV疫苗接种数据,比较SBVP与非SBVP地区13岁前出生青少年的覆盖率。
主要发现
- 2014至2018年女性一剂HPV疫苗覆盖率非SBVP地区低于SBVP地区;2013年例外,非SBVP地区77.93% vs SBVP地区67.13%。
- 2016年坎特伯雷引入混合模式疫苗交付项目后非SBVP地区覆盖率改善,2019至2023年两种模式覆盖率相近。
- 男性HPV疫苗覆盖率2018至2023年SBVP地区较高(2017年除外),随时间差距增大,2023年SBVP地区79.0% vs 非SBVP地区68.1%。
- COVID-19疫情期间覆盖率下降,疫情后SBVP地区覆盖率回升最快。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: In Aotearoa New Zealand (NZ), differing Human Papillomavirus (HPV) vaccination programs are utilized. In the present study, we describe one-dose HPV vaccination coverage under a school-based vaccination program (SBVP) in NZ and coverage under a primary care practice-based program, or mixed-model program (non-SBVP), amongst adolescents born 13 years earlier. METHODS: We describe coverage across the SBVP and non-SBVP regions through a repeated cross-sectional analysis, using HPV vaccination data from the Aotearoa Immunization Register. RESULTS: From 2014 to 2018, female one-dose HPV vaccination coverage was lower in the non-SBVP region than in the SBVP regions. 2013 is an exception, with higher coverage in the non-SBVP region than the SBVP region (77.93 % vs 67.13 %). Coverage improved in the non-SBVP region following the introduction of a mixed-model vaccine delivery program in 2016, and from 2019 to 2023 coverage was similar between the two models. Male vaccination coverage, whilst not showing the same drastic differences in coverage by region as the female coverage, was higher in the SBVP region from 2018 to 2023, with the exception of 2017. Over time the difference in male coverage between the SBVP and non-SBVP regions increased, reaching 79.0 % and 68.1 %, respectively, in 2023. Coverage declined during the COVID-19 pandemic, however, coverage increased after COVID-19 emergence most rapidly in SBVP regions. CONCLUSIONS: School-based delivery of HPV vaccines to adolescents in NZ was successful, with lower coverage seen under Canterbury's non-SBVP approach, although the introduction of a mixed schools and primary care practitioner program in Canterbury in 2016 did appear to improve coverage.
引用
- Cosgrove S, Hider P, Anglemyer A, et al. HPV vaccination in Aotearoa New Zealand: Impact of a school-based program on adolescent vaccine coverage. Vaccine. 2025. PMID: 40876142. doi:10.1016/j.vaccine.2025.127637
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。